Clinical Trial Update: OTL-200 in Patients With Late Juvenile Metachromatic Leukodystrophy (MLD) [Phase 3]

View source ↗

Summary

The update describes a Phase 3 trial of OTL-200 for late juvenile Metachromatic Leukodystrophy and notes the study is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metachromatic Leukodystrophy

Drugs mentioned

• OTL-200

Snippet

Sponsor: Orchard Therapeutics | Conditions: Lysosomal Storage Diseases, Metachromatic Leukodystrophy | Phase 3 | Status: ACTIVE_NOT_RECRUITING